The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on Percutaneous radiofrequency ablation for primary or secondary lung cancers.
It replaces the previous guidance on Percutaneous radiofrequency ablation for primary or secondary lung cancers (NICE interventional procedures guidance 185, July 2006).
Percutaneous radiofrequency ablation of cancer in the lung involves inserting one or more electrodes (needle-like probes) through the chest into the lung. The electrodes are placed within the tumour and connected to a source of electrical current, producing heat with the aim of destroying (‘ablating’) the cancer cells.
E59.5 Percutaneous radiofrequency ablation of lesion of lung
Y53.- Approach to organ under image control
Note: Codes within category Y53.- are used as secondary codes to classify interventions that are percutaneous and require some form of image control: if the method of image control is unspecified, Y53.9 Unspecified approach to organ under image control is assigned.
In addition, an ICD-10 code from category C34.- Malignant neoplasm of bronchus and lung or C78.0 Secondary malignant neoplasm of lung would be recorded.